UK Regulator Authorizes Eli Lilly Foundayo Weight Loss Pill
The UK medicines regulator has authorized Eli Lilly’s once-daily weight-loss pill Foundayo for weight management and type 2 diabetes, making Britain the first European country to clear the oral GLP-1 treatment. The drug is not yet available on the NHS pending a health technology appraisal. Eli Lilly has secured a major regulatory milestone in Europe … Read more